Melanie Ziman Selected Research

Melanie Ziman Research Topics

Disease

17	Melanoma (Melanoma, Malignant) 12/2020 - 09/2012
11	Neoplasms (Cancer) 10/2020 - 02/2010
4	Circulating Neoplastic Cells 01/2020 - 12/2018
2	Uveal melanoma 12/2020 - 11/2019
2	Disease Progression 11/2020 - 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Nevus (Nevi) 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2019
1	Carcinogenesis 01/2019
1	Breast Neoplasms (Breast Cancer) 02/2010
1	Arthritis (Polyarthritis) 05/2009
1	Rheumatoid Arthritis 05/2009
1	Ectromelia (Phocomelia) 04/2009
1	Infectious Ectromelia 04/2009
1	Infections 03/2008
1	Tuberculosis (Tuberculoses) 03/2008
1	T-Cell Leukemia (Leukemia, T Cell) 04/2006
1	Diarrhea 04/2005

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2015
6	Circulating Tumor DNAIBA 01/2020 - 12/2015
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2015
3	AntibodiesIBA 12/2020 - 03/2008
3	Immune Checkpoint InhibitorsIBA 01/2020 - 12/2019
3	pembrolizumabIBA 01/2020 - 12/2015
3	IpilimumabIBA 01/2020 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2008
2	Cell-Free Nucleic AcidsIBA 11/2020 - 10/2017
2	Biological ProductsIBA 01/2019 - 04/2009
2	Phosphotransferases (Kinase)IBA 12/2015 - 02/2010
2	VemurafenibIBA 12/2015 - 06/2014
2	Adapalene (Differin)FDA LinkGeneric 06/2014 - 09/2012
2	SuspensionsIBA 05/2009 - 03/2008
2	AntigensIBA 03/2008 - 04/2005
1	TropomyosinIBA 12/2020
1	AutoantibodiesIBA 12/2020
1	Immunoglobulin A (IgA)IBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Circulating MicroRNAIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 11/2019
1	LigandsIBA 06/2019
1	Conditioned Culture MediaIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Guanine NucleotidesIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2018
1	GTP-Binding Proteins (G-Protein)IBA 12/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	trametinibIBA 12/2015
1	NivolumabIBA 12/2015
1	dabrafenibIBA 12/2015
1	RNA (Ribonucleic Acid)IBA 10/2015
1	Dacarbazine (DIC)FDA LinkGeneric 06/2014
1	Indicators and Reagents (Reagents)IBA 06/2014
1	ErbB Receptors (EGF Receptor)IBA 02/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2010
1	tyrosine receptor (receptor, tyrosine)IBA 02/2010
1	ChemokinesIBA 05/2009
1	Infliximab (Remicade)FDA Link 05/2009
1	Immunologic Factors (Immunomodulators)IBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	CytokinesIBA 05/2009
1	Antirheumatic Agents (DMARD)IBA 05/2009
1	Rituximab (Mabthera)FDA Link 05/2009
1	Hepatitis B e AntigensIBA 03/2008
1	VaccinesIBA 03/2008
1	Serine (L-Serine)FDA Link 04/2006
1	Transcription Factors (Transcription Factor)IBA 04/2006
1	PhosphoproteinsIBA 04/2006
1	Tyrosine (L-Tyrosine)FDA Link 04/2006
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2006
1	Threonine (L-Threonine)FDA Link 04/2006

Therapy/Procedure

12	Therapeutics 11/2020 - 05/2009
3	Microspheres (Microsphere) 02/2010 - 04/2005
2	Immunotherapy 12/2020 - 12/2015